Labeling For Optimer's Dificid Includes Data On Ability To Sustain Cure Post-Treatment
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves the macrolide antibacterial for treatment of Clostridium difficile-associated diarrhea.